Novartis Oncology Financial Analyst Salaries in Boulder | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Financial Analyst Salaries in Boulder

The average Novartis Oncology Financial Analyst in Boulder earns an estimated $79,730 annually, which includes an estimated base salary of $73,397 with a $6,333 bonus. Novartis Oncology's Financial Analyst compensation is $7,670 less than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Oncology in Boulder can range from $57,500 - $86,000.

In Boulder, The Finance Department at Novartis Oncology earns $4,829 more on average than the Operations Department.

Last updated 3 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$79,730
Average Compensation
$73,397
avg. base
$6,333
avg. bonus

Financial Analyst Salaries at Novartis Oncology

In Boulder, Financial Analysts earn $1,730 more than Business Analysts, and $10,550 less than Senior Accountants.

Accounting Manager
$96k*
Senior Accountant
$90k*
Business Analyst
$78k*
Financial Analyst
$77k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Boulder, The Finance Department averages $4,829 more than the Operations Department, and $16,534 less than the Sales Department

Sales
$92,112 Avg. total comp.
+$17k
Finance
$75,578 Avg. total comp.
Operations
$70,749 Avg. total comp.
-$5k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Novartis Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at Novartis Oncology Rate Their Compensation

The majority of Financial Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Financial Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company